tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ABBV Stock Latest News

AbbVie’s Pediatric Bipolar Disorder Study: A Potential Game-Changer?
Company AnnouncementsAbbVie’s Pediatric Bipolar Disorder Study: A Potential Game-Changer?
3h ago
ABBV
AbbVie’s Promising Phase 2 Trial for Atopic Dermatitis: What Investors Need to Know
PremiumCompany Announcements
AbbVie’s Promising Phase 2 Trial for Atopic Dermatitis: What Investors Need to Know
3h ago
ABBV
AbbVie’s Promising Phase 2 Study on ADPKD Treatment: What Investors Should Know
PremiumCompany Announcements
AbbVie’s Promising Phase 2 Study on ADPKD Treatment: What Investors Should Know
3h ago
ABBV
AbbVie Bets $1.2 Billion on Psychedelic Depression Drug to Boost Mental Health Pipeline
PremiumMarket News
AbbVie Bets $1.2 Billion on Psychedelic Depression Drug to Boost Mental Health Pipeline
22h ago
JNJ
ABBV
AbbVie’s Promising Phase 3 Study on Etentamig for Multiple Myeloma
PremiumCompany Announcements
AbbVie’s Promising Phase 3 Study on Etentamig for Multiple Myeloma
1d ago
ABBV
AbbVie’s New AML Study: A Potential Game-Changer for Cancer Treatment
PremiumCompany AnnouncementsAbbVie’s New AML Study: A Potential Game-Changer for Cancer Treatment
1d ago
ABBV
AbbVie’s Latest Study on Psoriatic Arthritis: A Potential Game-Changer?
Premium
Company Announcements
AbbVie’s Latest Study on Psoriatic Arthritis: A Potential Game-Changer?
1d ago
ABBV
AbbVie’s Ubrogepant Study: A Potential Game-Changer for Pediatric Migraine Treatment
Premium
Company Announcements
AbbVie’s Ubrogepant Study: A Potential Game-Changer for Pediatric Migraine Treatment
1d ago
ABBV
AbbVie’s Promising Clinical Study on ABBV-319 for B-cell Malignancies
PremiumCompany Announcements
AbbVie’s Promising Clinical Study on ABBV-319 for B-cell Malignancies
1d ago
ABBV
AbbVie’s Innovative Approach in Treating Platinum-Resistant Ovarian Cancer
PremiumCompany Announcements
AbbVie’s Innovative Approach in Treating Platinum-Resistant Ovarian Cancer
1d ago
ABBV
Raymond James views Bretisilocin as solid addition to AbbVie’s Neuro pipeline
PremiumThe Fly
Raymond James views Bretisilocin as solid addition to AbbVie’s Neuro pipeline
3d ago
ABBV
AbbVie to acquire Gilgamesh’s bretisilocin program for up to $1.2B
PremiumThe Fly
AbbVie to acquire Gilgamesh’s bretisilocin program for up to $1.2B
3d ago
ABBV
AbbVie’s IMGN151 Study: A New Hope for Recurrent Gynecological Cancers
PremiumCompany AnnouncementsAbbVie’s IMGN151 Study: A New Hope for Recurrent Gynecological Cancers
4d ago
ABBV
AbbVie’s Promising CLL Study: A Potential Game-Changer for Investors
Premium
Company Announcements
AbbVie’s Promising CLL Study: A Potential Game-Changer for Investors
4d ago
ABBV
AbbVie’s Promising Phase 3 Study on Upadacitinib for Hidradenitis Suppurativa
Premium
Company Announcements
AbbVie’s Promising Phase 3 Study on Upadacitinib for Hidradenitis Suppurativa
4d ago
ABBV
AbbVie’s New Study to Shed Light on Disease Burden in Dermatology
PremiumCompany Announcements
AbbVie’s New Study to Shed Light on Disease Burden in Dermatology
4d ago
ABBV
AbbVie’s Upadacitinib Study: A Potential Game-Changer for Ulcerative Colitis Treatment?
PremiumCompany Announcements
AbbVie’s Upadacitinib Study: A Potential Game-Changer for Ulcerative Colitis Treatment?
4d ago
ABBV
AbbVie’s Upadacitinib Study: A Potential Game-Changer for Atopic Dermatitis Treatment?
PremiumCompany Announcements
AbbVie’s Upadacitinib Study: A Potential Game-Changer for Atopic Dermatitis Treatment?
4d ago
ABBV
AbbVie’s Promising Rheumatoid Arthritis Study: A Potential Game-Changer?
PremiumCompany Announcements
AbbVie’s Promising Rheumatoid Arthritis Study: A Potential Game-Changer?
4d ago
ABBV
AbbVie’s Atogepant Study: A New Hope for Menstrual Migraine Prevention
PremiumCompany AnnouncementsAbbVie’s Atogepant Study: A New Hope for Menstrual Migraine Prevention
4d ago
ABBV
AbbVie’s Promising Study on Targeted Therapies for Crohn’s Disease
Premium
Company Announcements
AbbVie’s Promising Study on Targeted Therapies for Crohn’s Disease
4d ago
ABBV
AbbVie’s SUNRISE-UC Study: A Real-World Evaluation of Risankizumab for Ulcerative Colitis
Premium
Company Announcements
AbbVie’s SUNRISE-UC Study: A Real-World Evaluation of Risankizumab for Ulcerative Colitis
4d ago
ABBV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >